Novel 2-heteroaryl substituted indoles 695

Details for Australian Patent Application No. 2008221667 (hide)

Owner AstraZeneca AB

Inventors Wensbo, David; Swahn, Britt-Marie; Arzel, Erwan

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008221667

PCT Pub. Number WO2008/108729

Priority 60/893,151 06.03.07 US

Filing date 5 March 2008

Wipo publication date 12 September 2008

International Classifications

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4439 (2006.01)

A61K 31/497 (2006.01)

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

10 September 2009 PCT application entered the National Phase

  PCT publication WO2008/108729 Priority application(s): WO2008/108729

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008221668-Novel 2-heteroaryl substituted benzothiophenes and benzofuranes 709

2008221661-Diagnosis of collagen IX destruction